Cargando…
1210. Prospective review of provider discontinuation of inappropriate intravenous (IV) vancomycin at a community teaching hospital in Chicago
BACKGROUND: Vancomycin is often started empirically for its reliability with gram-positive pathogens, particularly Methicillin Resistant Staph aureus (MRSA). Consequently, it is often over-prescribed. Antimicrobial stewardship programs (ASP) have used time-outs to ensure therapies are tailored to th...
Autores principales: | Oderinde, Jennifer, Chiang, Anthony, Juska, Alicia, ADEYEMI, O L U W A D A M I L O L A A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678991/ http://dx.doi.org/10.1093/ofid/ofad500.1050 |
Ejemplares similares
-
1209. Let’s take a time-out: Implementing a standardized process to assess the clinical use of vancomycin for pharmacists
por: Oderinde, Jennifer, et al.
Publicado: (2023) -
Characterization of a monoclonal antibody to L1210 leukaemia.
por: Testorelli, C., et al.
Publicado: (1982) -
Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
por: Orr, R. M., et al.
Publicado: (1994) -
DTIC xenogenized lines obtained from an L1210 clone: clonal analysis of cytotoxic T lymphocyte reactivity.
por: Marelli, O., et al.
Publicado: (1988) -
Development of cyclosporin A mediated immunity in L1210 leukaemia.
por: Slater, L. M., et al.
Publicado: (1991)